Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients

Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on perso...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Zhenglin, Li, Rongqi, Zhang, Jinhu, An, Lingyue, Zhou, Gaoxiang, Lei, Min, Deng, Jiwang, Yang, Riwei, Song, Zhenfeng, Zhong, Wen, Qi, Defeng, Duan, Xiaolu, Li, Shujue, Sun, Baoqing, Wu, Wenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646535/
https://www.ncbi.nlm.nih.gov/pubmed/36389789
http://dx.doi.org/10.3389/fimmu.2022.1008865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646535/
https://www.ncbi.nlm.nih.gov/pubmed/36389789
http://dx.doi.org/10.3389/fimmu.2022.1008865

Ejemplares similares